Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

buy
Chemocentryx Inc.

Start price
Target price
Perf. (%)
€29.94
20.10.21
€35.00
31.12.23
65.15%
05.08.22

Could be very worthwhile Investment >20% year
IfYouCanDreamItYouCanDoIt 
20.10.21 60%
buy
Global Blood Therapeutics Inc

Start price
Target price
Perf. (%)
€33.09
30.10.21
€45.00
31.12.23
94.65%
05.08.22

Could be very worthwhile Investment >20% year
IfYouCanDreamItYouCanDoIt 
30.10.21 50%
buy
Alnylam Pharmace.

Start price
Target price
Perf. (%)
€152.65
16.11.21
€200.00
31.01.25
36.59%
03.08.22

Could be worthwhile Investment >10% per year
IfYouCanDreamItYouCanDoIt 
16.11.21 70%
buy
Forte Biosciences Inc.

Start price
Target price
Perf. (%)
€1.19
27.06.22
€1.00
27.06.23
26.17%
09.07.22

Capable Management
Could be very worthwhile Investment >20% year
Few uniques
me8 
27.06.22 0%
buy
Agile Therapeutics Inc.

Start price
Target price
Perf. (%)
€79.50
27.06.22
€100.00
27.06.23
40.88%
28.06.22

Could be worthwhile Investment >10% per year
Capable Management
Very good company culture
Little innovation
me8 
27.06.22 0%
buy
Kezar Life Sciences

Start price
Target price
Perf. (%)
€10.20
16.11.21
€11.00
31.12.24
0.98%
28.06.22

Could be very worthwhile Investment >20% year
IfYouCanDreamItYouCanDoIt 
16.11.21 70%
sell
Bluebird Bio Inc.

Start price
Target price
Perf. (%)
€9.23
09.11.21
€7.00
31.12.23
-56.18%
28.06.22

Could be very worthwhile Investment >20% year
IfYouCanDreamItYouCanDoIt 
09.11.21 70%
buy
Forte Biosciences Inc.

Start price
Target price
Perf. (%)
€1.10
13.06.22
€1.00
13.06.23
7.81%
25.06.22

Capable Management
Could be very worthwhile Investment >20% year
Few uniques
me8 
13.06.22 0%
buy
Vertex Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€158.36
17.06.21
€165.00
17.06.22
59.60%
18.06.22

Could be worthwhile Investment >10% per year
melinda 
17.06.21 50%
buy
Vertex Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€158.36
17.06.21
€165.00
17.06.22
59.60%
18.06.22

Could be worthwhile Investment >10% per year
melinda 
17.06.21 50%
buy
Vertex Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€158.36
17.06.21
€165.00
17.06.22
59.60%
18.06.22

Could be worthwhile Investment >10% per year
melinda 
17.06.21 50%
buy
AstraZeneca plc

Start price
Target price
Perf. (%)
€91.61
03.06.21
€115.00
03.06.22
34.21%
04.06.22

ValueFreak 
03.06.21 80%
buy
AstraZeneca plc

Start price
Target price
Perf. (%)
€91.61
03.06.21
€115.00
03.06.22
34.21%
04.06.22

ValueFreak 
03.06.21 80%
buy
Zosano Pharma Corp.

Start price
Target price
Perf. (%)
€1.43
02.05.22
€1.00
02.05.23
18.02%
05.05.22

Could be worthwhile Investment >10% per year
Capable Management
Good culture
Growths slower than the competition
me8 
02.05.22 0%
buy
Avenue Therapeutics Inc.

Start price
Target price
Perf. (%)
€0.015
20.02.22
€7.50
20.03.22
61900.00%
21.03.22

Could be worthwhile Investment >10% per year
melinda 
20.02.22 50%
buy
Chemocentryx Inc.

Start price
Target price
Perf. (%)
€11.37
17.06.21
€18.00
09.03.22
95.60%
10.03.22

Could be very worthwhile Investment >20% year
melinda 
17.06.21 40%
buy
AstraZeneca plc

Start price
Target price
Perf. (%)
€83.63
10.03.21
€62.35
10.03.22
28.85%
10.03.22

FinanceClub_UoM 
10.03.21 50%
buy
AstraZeneca plc

Start price
Target price
Perf. (%)
€83.63
10.03.21
€62.35
10.03.22
28.85%
10.03.22

FinanceClub_UoM 
10.03.21 50%
buy
Epizyme Inc.

Start price
Target price
Perf. (%)
€1.10
27.01.22
€1.00
27.01.23
41.00%
05.02.22

Could be worthwhile Investment >10% per year
Capable Management
Bad culture
me8 
27.01.22 0%
buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€463.95
25.01.21
€500.00
25.01.22
15.42%
26.01.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
WatchMen 
25.01.21 0%
buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€463.95
25.01.21
€500.00
25.01.22
15.42%
26.01.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
WatchMen 
25.01.21 0%
buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€463.95
25.01.21
€500.00
25.01.22
15.42%
26.01.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
WatchMen 
25.01.21 0%
sell
Biogen Inc.

Start price
Target price
Perf. (%)
€243.10
18.10.21
€210.00
02.01.23
-12.53%
16.12.21

Could be worthwhile Investment >10% per year
IfYouCanDreamItYouCanDoIt 
18.10.21 60%
sell
Biogen Inc.

Start price
Target price
Perf. (%)
€243.10
18.10.21
€210.00
02.01.23
-12.53%
16.12.21

Could be worthwhile Investment >10% per year
IfYouCanDreamItYouCanDoIt 
18.10.21 60%
sell
Biogen Inc.

Start price
Target price
Perf. (%)
€243.10
18.10.21
€210.00
02.01.23
-12.53%
16.12.21

Could be worthwhile Investment >10% per year
IfYouCanDreamItYouCanDoIt 
18.10.21 60%